Veradermics (MANE) Shares Outstanding (Weighted Average) (2024 - 2026)

Veradermics (MANE) has 3 years of Shares Outstanding (Weighted Average) data on file, last reported at $22.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 2980.89% year-over-year to $22.7 million; the trailing twelve-month figure through Mar 2026 stood at $22.7 million (up 2980.89% YoY), and the FY2025 full-year result was $744991.0, up 1.09% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $22.7 million, up from $744991.0 in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $22.7 million in Q1 2026 and bottomed at $736933.0 in Q4 2024.
• The 3-year median for Shares Outstanding (Weighted Average) is $740962.0 (2024), against an average of $6.2 million.
• The widest annual swing landed in 2025, when Shares Outstanding (Weighted Average) climbed 1.09%; it then surged 2980.89% in 2026.
• A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $736933.0 in 2024, then rose by 1.09% to $744991.0 in 2025, then soared by 2947.57% to $22.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $22.7 million (Q1 2026), $744991.0 (Q4 2025), and $736933.0 (Q1 2025), per Business Quant data.

Peer Comparison